Unlike existing treatments that block individual cytokines such as IL-4, IL-13 or IL-31, therapies targeting the OX40 pathway ...

Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a ...

Shawn Kwatra, M.D., Joseph W. Burnett endowed professor and chair of dermatology at the University of Maryland School of ...

The use of interleukin (IL)-23 inhibitors plays an important role in treating patients with psoriasis, as well as in treating ...

New long-term data of the investigational therapy icotrokinra show that it is able to achieve site-specific clear or almost clear skin in patients with plaque psoriasis, according to results of the ...

Although it’s commonly recommended to test for albuminuria in people with diabetes or high blood pressure, testing is often ...

Foluso Agboola discusses the Institute for Clinical and Economic Review's newest analysis, which has found that most new ...

Employer health premiums rose significantly this year, impacting healthcare costs and insurance access. A KFF survey reveals trends in coverage and employee contributions. Average annual premiums for ...

An expert discusses how underutilization of combination lipid-lowering therapies stems from overly complex guidelines, ...

These gaps stem from systemic barriers, including limited access to early detection, follow-up delays and inequities in ...

A new digital health tool increased rates of lung cancer screening, according to research published Oct. 20 in JAMA. Investigators from Wake Forest University School of Medicine, ...

The new treatments Gilhooley referred to are calcitonin gene-related peptide (CGRP) inhibitors, a class that includes ...